Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Musculoskeletal embryonic nuclear protein 1 is a small nuclear protein (~9.6 kDa, approx. 80-82 amino acids), present mainly in bone, cartilage, skeletal muscle, and tendon. It is evolutionarily conserved among vertebrates and expressed in both embryonic and adult tissues of the musculoskeletal system. MUSTN1 expression is regulated by the AP-1 family of transcription factors, including c-Fos, Fra-2, and JunD. Functional studies indicate that MUSTN1 is essential for normal muscle cell (myoblast) and cartilage (chondrocyte) differentiation, growth, and regeneration. It is not a classical transcription factor as it lacks a DNA-binding domain, but likely acts as a co-activator or co-regulator in transcriptional complexes during musculoskeletal development. Increased expression of MUSTN1 is seen during musculoskeletal tissue repair and in certain disease states, making it useful as a biomarker of lineage commitment and regeneration, although it currently has no direct drug interventions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Musculoskeletal embryonic nuclear protein 1 (MUSTN1).